EXHIBIT 10.48

                                                                  CONFORMED COPY

                       FIRST AMENDMENT TO CREDIT AGREEMENT

               This FIRST AMENDMENT TO CREDIT AGREEMENT (this "Amendment") is
dated as of October 30, 2002, and entered into by and among ALLERGAN, INC. (the
"Company"), the banks and other financial institutions signatory hereto that are
parties as Banks to the Credit Agreement referred to below (the "Banks"),
JPMORGAN CHASE BANK, as administrative agent (in such capacity, the
"Administrative Agent"), CITICORP USA INC., as syndication agent, and BANK OF
AMERICA, N.A., as documentation agent.

                                    Recitals

               A. The Company, the Banks, and the Agents have entered into that
certain Credit Agreement dated as of October 11, 2002, (the "Credit Agreement"),
by and among the Company, the Eligible Subsidiaries referred to therein, the
Banks party thereto, the Administrative Agent, Citicorp USA Inc., as syndication
agent, and Bank of America, N.A., as documentation agent. Capitalized terms used
in this Amendment without definition shall have the meanings given such terms in
the Credit Agreement.

               B. The Company has requested certain amendments to the Credit
Agreement.

               C. The Banks and the Administrative Agent are willing to agree to
the amendments requested by the Company, on the terms and conditions set forth
in this Amendment.

                                    Agreement

               NOW THEREFORE, in consideration of the premises and the mutual
agreements set forth herein, the Company, the Banks, and the Administrative
Agent agree as follows:

               1. Amendments to Section 1.01 of the Credit Agreement. The
definition of Consolidated Net Worth contained in Section 1.01 of the Credit
Agreement is hereby amended in its entirety to read as follows:

                  "Consolidated Net Worth" means at any date (i) the
          consolidated stockholders' equity of the Company and its Consolidated
          Subsidiaries determined as of such date less (ii) (to the extent
          reflected in determining such consolidated stockholders' equity) all
          write-ups (other than write-ups resulting from foreign currency
          translations and write-ups of assets of a going concern business made
          within twelve months after the acquisition of such business)
          subsequent to June 28, 2002 in the book value of any asset owned by
          the Company or a Consolidated Subsidiary plus (iii) the amount of the
          reduction in such consolidated stockholders' equity which results
          directly from the lump sum payment made pursuant to the Settlement
          Agreement between the Company, et.al., on the one hand, and Pharmacia
          Corporation, et.al., and Columbia University, on the other hand, dated
          October 2002, resolving intellectual property disputes involving

                                       1



          Lumigan(R) and the lump sum payment relating thereto; provided that
          the amount of the addition pursuant to this clause (iii) shall not
          exceed $100,000,000.

               2. Representations and Warranties. The Company represents and
warrants that:

                  (a) Corporate Existence and Power. The Company is a
          corporation duly incorporated, validly existing and in good standing
          under the laws of Delaware, and has all corporate powers and all
          material governmental licenses, authorizations, consents and approvals
          required to carry on its business as now conducted.

                  (b) Corporate and Governmental Authorization. The execution,
          delivery and performance by the Company of this Amendment and the
          performance by the Company of the Credit Agreement, as amended by this
          Amendment (the "Amended Credit Agreement"), are within the Company's
          corporate powers, have been duly authorized by all necessary corporate
          action, require no action by or in respect of, or filing with, any
          governmental body, agency or official under any provision of law or
          regulation applicable to the Company, and do not contravene, or
          constitute a default under, any provision of law or regulation
          applicable to the Company or of the restated certificate of
          incorporation or by-laws of the Company or of any agreement, judgment,
          injunction, order, decree or other instrument binding upon the Company
          or any of its Subsidiaries or result in the creation or imposition of
          any Lien on any asset of the Company or any of its Subsidiaries.

                  (c) Binding Effect. This Amendment and the Amended Credit
          Agreement constitute the legal, valid and binding obligations of the
          Company.

                  (d) No Default. Immediately before and after giving effect to
          this Amendment, no Default has occurred and is continuing.

               3. Effectiveness. This Amendment shall be effective on the date
when this Amendment shall have been signed by, and counterparts hereof shall
have been delivered to the Administrative Agent (by hand delivery, mail or
telecopy), the Company and the Required Banks.

                                        2



               4. Effect of Amendment; Ratification. From and after the date on
which this Amendment becomes effective, all references to the Credit Agreement
shall mean the Credit Agreement as amended hereby. Except as expressly amended
hereby or waived herein, the Credit Agreement and the Notes shall remain in full
force and effect, and all terms and provisions thereof are hereby ratified and
confirmed. The Company confirms that as amended hereby, each of the Amended
Credit Agreement and the Notes is in full force and effect.

               5. Governing Law. This Amendment shall be governed by and
construed in accordance with the laws of the State of New York.

               6. Counterparts; Integration. This Amendment maybe signed in any
number of counterparts, each of which shall be an original, with the same effect
as if the signatures thereto and hereto were upon the same instrument. This
Amendment constitutes the entire agreement and understanding among the parties
hereto and supersedes and any all prior agreements and understandings, oral or
written, related to the subject matter hereof.

                                       3



               IN WITNESS WHEREOF, each of the undersigned has duly executed
this First Amendment to Credit Agreement as of the date set forth above.

                                   ALLERGAN, INC.

                                   By: /s/ Eric K. Brandt
                                       Name:  Eric K. Brandt
                                       Title: Corporate Vice President and Chief
                                              Financial Officer


                                   By: /s/ James M. Hindman
                                       Name:  James M. Hindman
                                       Title: Senior Vice President, Treasury,
                                              Risk and Investor Relations

                                   JPMORGAN CHASE BANK


                                   By: /s/ Dawn Lee Lum
                                       Name:  Dawn Lee Lum
                                       Title: Vice President


                                   CITICORP USA, INC.


                                   By: /s/ Deborah Ironson
                                       Name:  Deborah Ironson
                                       Title: Vice-President

                                       S-1



                                   BANK OF AMERICA, N.A.


                                   By: /s/ Joseph L. Corah
                                       Name:  Joseph L. Corah
                                       Title: Principal

                                   BANK ONE, NA


                                   By: /s/ Joseph Perdenza
                                       Name:  Joseph Perdenza
                                       Title: Director

                                       S-2